RICH logo

Laboratorios Richmond S.A.C.I.F. Stock Price

BASE:RICH Community·AR$132.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

RICH Share Price Performance

AR$1,600.00
290.00 (22.14%)
AR$1,600.00
290.00 (22.14%)
Price AR$1,600.00

RICH Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with poor track record.

5 Risks
0 Rewards

Laboratorios Richmond S.A.C.I.F. Key Details

AR$126.7b

Revenue

AR$48.3b

Cost of Revenue

AR$78.5b

Gross Profit

AR$76.0b

Other Expenses

AR$2.4b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
29.77
61.91%
1.90%
242.6%
View Full Analysis

About RICH

Founded
1959
Employees
n/a
CEO
Juan Manuel Artola
WebsiteView website
www.richmondlab.com

Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company was incorporated in 1959 and is headquartered in Buenos Aires, Argentina.

Recent RICH News & Updates

Recent updates

No updates

Laboratorios Richmond S.A.C.I.F. Competitors